Despite ongoing financial pressures in the healthcare industry, ASCs remain a resilient and growing force. While some predict financial constraints will drive consolidation, many industry leaders are confident ASCs will continue to thrive.
Author: Patsy Newitt
Becker's has reported on three ASC closures in the last month:
From contract disputes to alleged discrimination, legal action has developed involving several physicians against their former employers in the last month.
Physician autonomy is top of mind for many healthcare leaders as the number of independent physicians dwindles.
The ASC industry continued to expand in 2024, with major players pursuing aggressive growth strategies through acquisitions, joint ventures and de novo developments.
Advertisement
An Orchard Park, N.Y.-based radiologist is suing his former practice, claiming he was shortchanged when it sold assets to private equity firm Rezolut for $20 million in 2023, Buffalo Business First reported Feb. 27.
Ontario, Calif.-based Prime Healthcare completed its acquisition of eight Ascension hospitals and two ASCs in Illinois.
Guardant Health has filed a lawsuit against its competitor, Natera, alleging the misappropriation of trade secrets related to cancer-detection blood tests, according to court documents.
Brentwood, Tenn.-based Surgery Partners' deployed nearly $400 million on acquisitions and opened eight de novo facilities in 2024, according to the company's financial report released March 3.
Three ASC leaders joined Becker's to discuss how reimbursement rates affect ASC operations